AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 287: H2341-H2345, 2004. First published July 15, 2004; doi:10.1152/ajpheart.00179.2004
0363-6135/04 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
287/5/H2341    most recent
00179.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Torres, L. N.
Right arrow Articles by Pittman, R. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Torres, L. N.
Right arrow Articles by Pittman, R. N.

Continuous peripheral resistance measurement during hemorrhagic hypotension

Luciana N. Torres,1,2 Ivo P. Torres Filho,1,2,3 R. Wayne Barbee,1,2 M. Hakam Tiba,2 Kevin R. Ward,1,2 and Roland N. Pittman1,2

Departments of 1Physiology, 2Emergency Medicine, and 3Anesthesiology, Virginia Commonwealth University Reanimation Engineering Shock Center, Virginia Commonwealth University Health System, Richmond, Virginia 23298-0401

Submitted 24 February 2004 ; accepted in final form 18 June 2004

We tested the hypotheses that continuous total peripheral resistance (TPR) measurements are superior to intermittent data collection and that variables related to TPR can be used to distinguish between survivors and nonsurvivors (NS), respectively, of prolonged hemorrhagic hypotension (HH). One week after a transit-time ultrasound probe was implanted on their ascending aortas, 21 rats were subjected to 4 h of HH at 40 mmHg. Measurements were made before and up to 4 h after initiation of HH. Additional bleeding or Ringer L-lactate (RL) infusion was used to maintain HH. TPR was continuously measured online using recordings of blood flow and arterial pressure. Approximately 67% of the rats survived ≥3 h; others were considered NS. Data collected at 30-min intervals failed to detect the maximum value of TPR (TPRmax). The times to reach TPRmax were similar for survivors and NS and were strongly correlated with the bleeding end points and with the RL infusion-onset times. However, survivors showed higher TPRmax values than NS (P < 0.005) and had a significantly longer period than NS during which TPR was above baseline level (116 ± 20 vs. 51 ± 10 min). In conclusion, 1) the transit-time ultrasound technique at high sampling rate allowed continuous and accurate real-time monitoring of TPR, 2) the bleeding end point and RL infusion-onset times may be used as surrogates of the time to TPRmax, 3) TPRmax of survivors and NS could be detected only using a continuous TPR measurement, and 4) differences between survivors and NS could be revealed by the continuous TPR curve.

hemorrhage; blood pressure; total peripheral resistance; cardiac output; transit-time ultrasound



Address for reprint requests and other correspondence: L. N. Torres, Dept. of Emergency Medicine, MCV-VCU, 401 N. 12th St., Richmond, VA 23298-0401 (E-mail: LNTORRES{at}vcu.edu)




This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
J. L. Atkins, B. W. Day, M. T. Handrigan, Z. Zhang, M. B. Pamnani, and N. V. Gorbunov
Brisk production of nitric oxide and associated formation of S-nitrosothiols in early hemorrhage
J Appl Physiol, April 1, 2006; 100(4): 1267 - 1277.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.